SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-021983
Filing Date
2021-04-29
Accepted
2021-04-29 16:19:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A kura-defa14a_20210429.htm DEFA14A 29065
2 GRAPHIC gyct0fdw2vtk000002.jpg GRAPHIC 38204
3 GRAPHIC gyct0fdw2vtk000001.jpg GRAPHIC 118097
  Complete submission text file 0001564590-21-021983.txt   245616
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37620 | Film No.: 21870923
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences